Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23849 | 23430399 | Med Mol Morphol | A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. | 2013 | Details |
| A23850 | 23430039 | World J Gastroenterol | What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? | 2013 | Details |
| A23856 | 23425054 | J Gastroenterol Hepatol | Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis. | 2013 | Details |
| A23858 | 23424927 | Rev Prat | [Treatment of nonalcoholic steatohepatitis]. | 2012 | Details |
| A23859 | 23424926 | Rev Prat | [Management of non alcoholic fatty liver diseases in adults]. | 2012 | Details |
| A23862 | 23423795 | J Magn Reson Imaging | Magnetic resonance elastography of liver: technique, analysis, and clinical applications. | 2013 | Details |
| A23867 | 23418085 | Obesity (Silver Spring) | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. | 2013 | Details |
| A23883 | 23405244 | PLoS One | Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example. | 2013 | Details |
| A23885 | 23403440 | J Pediatr Gastroenterol Nutr | Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. | 2013 | Details |
| A23896 | 23397556 | Semin Thromb Hemost | Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. | 2013 | Details |
| A23904 | 23394096 | Curr Pharm Des | Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD. | 2013 | Details |
| A23907 | 23394093 | Curr Pharm Des | From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. | 2013 | Details |
| A23908 | 23394092 | Curr Pharm Des | Pathophysiology of NASH: perspectives for a targeted treatment. | 2013 | Details |
| A23909 | 23394091 | Curr Pharm Des | Epidemiology and natural history of patients with NAFLD. | 2013 | Details |
| A23910 | 23394090 | Curr Pharm Des | Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23912 | 23392740 | Pathologe | [Non-alcoholic steatohepatitis and cirrhosis in young adult patients with hypothalamic-pituitary dysfunction]. | 2013 | Details |
| A23913 | 23391869 | J Clin Gastroenterol | The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23917 | 23390441 | Korean J Pediatr | The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. | 2013 | Details |
| A23918 | 23390127 | Hepatology | Dietary fructose in nonalcoholic fatty liver disease. | 2013 | Details |
| A23922 | 23387384 | Obes Rev | Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. | 2013 | Details |
| A23926 | 23383649 | Aliment Pharmacol Ther | Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. | 2013 | Details |
| A23928 | 23382293 | Radiology | Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. | 2013 | Details |
| A23929 | 23382291 | Radiology | Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. | 2013 | Details |
| A23947 | 27785221 | Gastroenterology Res | Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23950 | 23356584 | Liver Int | Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. | 2013 | Details |
| A23951 | 23355916 | World J Hepatol | Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. | 2012 | Details |
| A23952 | 23355910 | World J Hepatol | Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome? | 2012 | Details |
| A23953 | 23355909 | World J Hepatol | Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment. | 2012 | Details |
| A23963 | 23347840 | Clin Res Hepatol Gastroenterol | Non-alcoholic steatohepatitis in morbidly obese patients. | 2013 | Details |
| A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
| A23983 | 23328905 | Curr Atheroscler Rep | Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review. | 2013 | Details |
| A23988 | 23325287 | Eur J Gastroenterol Hepatol | Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? | 2013 | Details |
| A23998 | 23316084 | J Clin Endocrinol Metab | Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. | 2013 | Details |
| A23999 | 23315950 | Hepatology | Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. | 2013 | Details |
| A24002 | 23313215 | J Proteomics | Changes in the hepatic mitochondrial and membrane proteome in mice fed a non-alcoholic steatohepatitis inducing diet. | 2013 | Details |
| A24003 | 23312215 | J Diabetes Complications | Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. | 2013 | Details |
| A24004 | 23307045 | J Gastroenterol | Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. | 2013 | Details |
| A24006 | 23305254 | Int J Exp Pathol | An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. | 2013 | Details |
| A24007 | 23305008 | Klin Lab Diagn | [The unity of pathogenesis of insulin resistance syndrome and non-alcoholic fatty disease of liver. The metabolic disorder of fatty acids and triglycerides]. | 2012 | Details |
| A24011 | 23303872 | J Nutr | Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. | 2013 | Details |
| A24014 | 23301938 | J Gastroenterol Hepatol | Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis. | 2013 | Details |
| A24016 | 23300059 | Hepatology | Hedgehog pathway and pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A24017 | 23299992 | Hepatology | Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. | 2013 | Details |
| A24025 | 23295058 | Liver Int | Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats. | 2013 | Details |
| A24030 | 23294411 | Hepatol Res | Transient elastography for monitoring the fibrosis of non-alcoholic fatty liver disease for 4 years. | 2013 | Details |
| A24031 | 23293873 | Aliment Pharmacol Ther | Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A24037 | 23293196 | Ann Hepatol | Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. | 2013 | Details |
| A24046 | 23285030 | PLoS One | Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. | 2012 | Details |
| A24049 | 23280158 | Dig Liver Dis | Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. | 2012 | Details |
| A24050 | 23278404 | J Gastroenterol Hepatol | Impact of leptin receptor gene variants on risk of non-alcoholic fatty liver disease and its interaction with adiponutrin gene. | 2013 | Details |
| A24052 | 23278163 | Aliment Pharmacol Ther | Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. | 2012 | Details |
| A24058 | 31528500 | J Carcinog Mutagen | Exocycilic DNA Adducts in a Murine Model of Non-alcoholic Steatohepatitis. | 2013 | Details |
| A24059 | 25702427 | Klin Med (Mosk) | [Proinflammatory cytokine levels depending on the stage of hepatic fibrosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2013 | Details |
| A24060 | 25674420 | Springerplus | (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis. | 2013 | Details |
| A24064 | 24772867 | Eksp Klin Gastroenterol | [Non-invasive techniques in diagnosis of steatosis and fibrosis in nonalcoholic fatty liver disease]. | 2013 | Details |
| A24067 | 24648894 | Biomed Rep | Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2012 | Details |
| A24070 | 23268566 | Scand J Gastroenterol | The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis - ultrastructural findings. The first report in pediatric patients. | 2012 | Details |
| A24074 | 23262638 | Toxicol Pathol | Toxicant-associated steatohepatitis. | 2012 | Details |
| A24079 | 23258240 | Recenti Prog Med | [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation]. | 2012 | Details |
| A24086 | 23238855 | Endocr Rev | Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. | 2012 | Details |
| A24087 | 23238106 | J Hepatol | A 360-degree overview of paediatric NAFLD: recent insights. | 2012 | Details |
| A24101 | 23227839 | Biomark Med | Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects? | 2012 | Details |
| A24102 | 23227347 | Int J Hepatol | Posttransplant metabolic syndrome. | 2012 | Details |
| A24104 | 23227248 | PLoS One | Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. | 2012 | Details |
| A24111 | 23221052 | Nihon Shokakibyo Gakkai Zasshi | [Clinical characteristics of non-alcoholic steatohepatitis (NASH) patients who progressed from F3 stage fibrosis to cirrhotic NASH]. | 2012 | Details |
| A24113 | 23218652 | Gastroenterol Hepatol | [Acute liver failure after bariatric surgery. A case report and literature review]. | 2012 | Details |
| A24114 | 23216963 | Hepatol Res | Evaluation of the Liver Fibrosis Index calculated by using real-time tissue elastography for the non-invasive assessment of liver fibrosis in chronic liver diseases. | 2012 | Details |
| A24116 | 23214350 | Acta Gastroenterol Latinoam | [Transient elastography: noninvasive assessment of liver fibrosis. Report of 1,000 cases in Argentina]. | 2012 | Details |
| A24133 | 23197236 | Med Sci Monit | The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. | 2012 | Details |
| A24135 | 25755455 | J Clin Exp Hepatol | A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis. | 2012 | Details |
| A24142 | 23184095 | J Gastroenterol | Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. | 2012 | Details |
| A24143 | 23183525 | J Hepatol | Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. | 2012 | Details |
| A24146 | 23179302 | Clin Exp Med | Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. | 2012 | Details |
| A24153 | 23175136 | Hepatology | Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. | 2013 | Details |
| A24172 | 23154483 | J Pediatr Gastroenterol Nutr | Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A24173 | 23152415 | Clin Chem Lab Med | High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis. | 2013 | Details |
| A24175 | 23147992 | Br J Surg | Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. | 2012 | Details |
| A24176 | 23146095 | Liver Int | Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. | 2012 | Details |
| A24177 | 23145208 | Am J Transl Res | Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. | 2012 | Details |
| A24181 | 23142622 | J Hepatol | Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. | 2012 | Details |
| A24191 | 23136827 | Biomarkers | Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases. | 2012 | Details |
| A24201 | 23127227 | Clin Exp Pharmacol Physiol | Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway. | 2012 | Details |
| A24207 | 23123425 | Food Chem Toxicol | Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. | 2012 | Details |
| A24208 | 23121401 | Liver Int | Liver involvement in Turner syndrome. | 2012 | Details |
| A24217 | 23112047 | J Biol Chem | Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model. | 2012 | Details |
| A24224 | 23107446 | J Dig Dis | Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24225 | 23101984 | Clin Liver Dis | Alcohol's effect on other chronic liver diseases. | 2012 | Details |
| A24226 | 23094755 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease in Asia: a story of growth. | 2013 | Details |
| A24227 | 23092327 | Curr Pharm Des | Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A24228 | 23091922 | Rev Med Brux | [Non alcoholic fatty liver disease assessment]. | 2012 | Details |
| A24229 | 23075871 | Dig Dis | Clinical spectrum and therapy of non-alcoholic steatohepatitis. | 2012 | Details |
| A24230 | 23075870 | Dig Dis | Nonalcoholic fatty liver disease: what the pathologist can tell the clinician. | 2012 | Details |
| A24232 | 23073870 | Intern Emerg Med | Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. | 2012 | Details |
| A24233 | 23073869 | Intern Emerg Med | Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS). | 2012 | Details |
| A24239 | 23087670 | Front Neurol | Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? | 2012 | Details |
| A24260 | 23067270 | Hepatol Res | Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis. | 2012 | Details |
| A24261 | 23066946 | Aliment Pharmacol Ther | Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers. | 2012 | Details |
| A24265 | 23066023 | J Biol Chem | Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. | 2012 | Details |
| A24266 | 23065020 | J Gastroenterol | The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. | 2012 | Details |
| A24273 | 23059409 | J Clin Gastroenterol | Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. | 2013 | Details |